Five-year median 32.4×, middle half 27.2–39.6×, range 20.6–57.5×. Now 60.1×: +86% above its own median, higher than 100% of those quarters.Each quarter priced at its own trailing Cash FFO per share · the band is the 25th–75th percentile
Where the cash goes
TTM through Sep 30, 2026 · $B
Cash FFO 3.02B = net income 1.46B + depreciation 2.68B − 1.12B other non-cash items · dividends 2.32B · retained 0.71B
Against its type
WELL (blue) vs. the other Healthcare REITs on the board (3), grey
P/Cash FFO60.1× vs. 17.6×
Dividend yield1.3% vs. 4.8%
Cash FFO payout77% vs. 76%
Net debt / EBITDA5.4× vs. 4.9×
Interest cover4.3× vs. 4.4×
EBITDA margin24% vs. 60%
Type averages are the plain mean of the other REITs of the same property type with a usable window.
Quarter by quarter
8 quarters · Dec 31, 2024 → Sep 30, 2026 · a gap is a dropped quarter